In this episode, we speak with Anita Brickman, CEO of the Plasma Protein Therapeutics Association (PPTA), about the crucial and often misunderstood role of plasma-derived therapies in respiratory health. The discussion highlights how essential plasma donors are for the creation of life-saving medicines used to treat Alpha-1 Antitrypsin Deficiency (AATD) and other rare, chronic conditions. Together, we explore the rigorous global safety standards, the difference between plasma-derived therapies and traditional drugs, and the ongoing challenge of meeting the growing worldwide need for plasma donations.👇 Learn more and explore additional resources:🔹 Episode recap and resources https://chroniclungdiseases.com/en/news/understanding-patient-support-programs-in-alpha-1/🔹 Living Well with COPD – AATD Module (free) https://chroniclungdiseases.com/register🔹 Plasma Week www.plasmaweek.org 🔹 Alpha-1 www.alpha1.org🔹 PPTA Global www.PPTAGlobal.org🔹 AlphaNet Canada https://alphanetcanada.ca/🔹 Canadian Thoracic Society AATD Guidelines https://www.tandfonline.com/doi/full/10.1080/24745332.2024.2443178🔹 Learn more about Season 5 https://chroniclungdiseases.com/en/the-expand-podcast-season-5-aatd/🔹 Watch more episodes about Alpha-1 https://www.youtube.com/playlist?list=PLKERLVA6ikI5X8SabIgyphzutdp8RyKUBThis podcast is produced by RESPIPLUS™ with support from Takeda Canada to raise awareness about Alpha-1 and improve access to care across Canada.

In Episode 4 of Season 5 of the Expand Podcast, we sit down with Shanta Zurock, a clinical pharmacist and healthcare access expert, to explore the complex system challenges surrounding Alpha-1 Antitrypsin Deficiency (AATD) in Canada.Drawing from decades of experience in pharmaceutical care, Ms. Zurock offers a behind-the-scenes look at drug access, insurance navigation, and policy barriers that affect patients with rare diseases like AATD. This episode is a must-listen for healthcare professionals, advocates, and patients seeking to understand how the system works—and how to make it better.👇 Learn more and explore additional resources:🔹 Episode recap and resources https://chroniclungdiseases.com/en/news/understanding-patient-support-programs-in-alpha-1/🔹 Living Well with COPD – AATD Module (free) https://chroniclungdiseases.com/register🔹 Canadian Thoracic Society AATD Guidelines https://www.tandfonline.com/doi/full/10.1080/24745332.2024.2443178🔹 Learn more about Season 5 https://chroniclungdiseases.com/en/the-expand-podcast-season-5-aatd/🔹 Watch more episodes about Alpha-1 https://www.youtube.com/playlist?list=PLKERLVA6ikI5X8SabIgyphzutdp8RyKUBThis podcast is produced by RESPIPLUS™ with support from Takeda Canada to raise awareness about Alpha-1 and improve access to care across Canada.The eXpand Podcast episodes are available in english and french or with french subtitles available in the english version.Subscribe to The eXpand Podcast: • YouTube: https://bit.ly/eXpandPodcastYouTube• Apple Podcast: https://bit.ly/eXpandPodcastApple• Spotify: https://bit.ly/eXpandPodcastSpotify• Google Podcasts: https://bit.ly/eXpandPodcastGoogle#theexpandpodcast #alpha1 #aatdAlpha-1 antitrypsin deficiency, lung disease, patient advocacy, augmentation therapy, healthcare access, chronic obstructive pulmonary disease, genetic conditions, awareness, diagnosis, treatment

In today’s podcast we’ll talk about cardiovascular diseases, their risk factors, and their relationship with COVID-19.

Our guest is Dr. Kim Connely, a cardiologist well-known nationally and internationally for his expertise in echocardiography, cardiovascular MRI, and diabetes.

Today you’ll learn about:

• An introduction to cardiovascular diseases and risk factors
• The impact of COVID-19 on cardiovascular diseases
• The role of lifestyle modifications and prevention measures
• The importance of research in cardiovascular diseases
• The role of vaccinations in preventing complications from COVID-19

Access free resources related to this episode:

Watch more episodes related to COVID-19: https://www.youtube.com/playlist?list=PLKERLVA6ikI7Q-UToML5HBvDkq7UWOIBE

#copd #theexpandpodcast

In today's podcast episode, we're diving deep into the topic of Long COVID and its impact on respiratory health.

You’ll learn about:

• The effects of Long-COVID on respiratory health
• The groundbreaking research being conducted in this field
• The role of autoimmunity in disease severity and its connection to COVID and Long-COVID

Access free resources related to this episode: https://chroniclungdiseases.com/en/news/navigating-the-unknown-terrain-of-long-covid/

Watch more episodes related to COVID-19: https://www.youtube.com/playlist?list=PLKERLVA6ikI7Q-UToML5HBvDkq7UWOIBE

#theexpandpodcast #copd #healthcanada

Access free resources related to this episode: https://chroniclungdiseases.com/en/news/copd-techniques/

Join us for a special episode capping off the last season of the eXpand Podcast!

In this week’s episode of the eXpand Podcast, we'll explore COPD diagnosis, management, and the importance of self-management and education for patients.

We emphasized the need for more awareness and resources for patients and healthcare professionals regarding bronchiectasis.

Our guest speaker is Isabelle LeClerc, a Registered Nurse with over 35 years of experience.

Today you’ll learn about:

• The importance of understanding bronchiectasis and its symptoms.
• The importance of patient education and self-management.
• The role of airway clearance techniques in managing bronchiectasis.
• The use of devices such as the Aerobika in aiding patients with airway clearance.
• The need for a bronchiectasis registry in Canada and more resources for patients and healthcare professionals.

Stay tuned for our upcoming season of the eXpand Podcast, coming soon.

#copd #healthcanada #theexpandpodcast

Les pharmaciens jouent un rôle crucial dans la gestion des maladies respiratoires chroniques.

Mais ils sont confrontés à de nombreux défis dans la gestion de ces maladies, notamment le manque d'accès aux dossiers médicaux et les difficultés à gérer les sorties d'hôpital.

Dans l'épisode d'aujourd'hui, nous avons rencontré Marie-France Beauchesne pour discuter de la façon dont la pratique de la pharmacie évolue vers une répartition plus équilibrée entre la distribution des médicaments et les soins cliniques.

Aujourd'hui, vous apprendrez :

• Le rôle des pharmaciens dans la gestion des maladies respiratoires chroniques

• L'évolution de ce rôle et son potentiel futur pour participer plus activement aux soins des patients

• Les défis auxquels sont confrontés les pharmaciens dans la gestion de ces maladies

• L'importance de l'éducation des patients et de l'adhésion aux médicaments

Accéder à des ressources gratuites en rapport avec cet épisode : https://chroniclungdiseases.com/fr/nouvelles/vivre-plus-longtemps-avec-une-mpoc/

Abonnez-vous à The eXpand Podcast :

- YouTube : https://bit.ly/eXpandPodcastYouTube

- Apple Podcast : https://bit.ly/eXpandPodcastApple

- Spotify : https://bit.ly/eXpandPodcastSpotify

- Google Podcasts : https://bit.ly/eXpandPodcastGoogle

#theexpandpodcast #copd #healthcanada

Chronic Obstructive Pulmonary Disease (COPD) remains an underfunded and underdiagnosed health issue in the United States. It is often referred to as a "silent epidemic" due to its prevalence and the lack of awareness and resources dedicated to it.

In today’s episode of the eXpand Podcast, the discussion centers around the state of COPD care, research, and awareness, as well as the role of the COPD Foundation in driving change in the delivery of care.

Our guest is Dr. Jean Wright, CEO of the COPD Foundation.Access free resources related to this episode: https://chroniclungdiseases.com/en/news/copd-chronicles-tracing-the-journey/

Watch more episodes related to COPD: https://www.youtube.com/playlist?list=PLKERLVA6ikI5K7cWnokHO9CFyvmTCDEp2

This episode was made in collaboration with COPD Foundation.

#copd #theexpandpodcast

In the world of medical research, Chronic Obstructive Pulmonary Disease (COPD) has often been a neglected subject. Yet, recent developments have highlighted the pressing need to refocus our attention on this debilitating condition.

From addressing gender disparities in COPD research to the vital role of organizations like GOLD (Global Initiative for Chronic Obstructive Lung Disease), we'll dive into the shifting landscape of COPD studies.

Our guest is Dr. Milan Han, Professor of Medicine and Chief of the Division of Pulmonary and Critical Care at the University of Michigan.

Today you’ll learn:

• The evolving landscape of COPD research and treatment
• The importance of early diagnosis and intervention in COPD
• The impact of various risk factors beyond smoking on COPD development
• The role of cohort studies in advancing understanding of COPD

This episode was made in collaboration with GOLD.

Access free resources related to this episode: https://chroniclungdiseases.com/en/news/copd-of-all-severities

Watch more episodes related to COPD: https://www.youtube.com/playlist?list=PLKERLVA6ikI5K7cWnokHO9CFyvmTCDEp2

The eXpand Podcast episodes are available in english and french or with french subtitles available in the english version.

Subscribe to The eXpand Podcast: • YouTube: https://bit.ly/eXpandPodcastYouTube • Apple Podcast: https://bit.ly/eXpandPodcastApple • Spotify: https://bit.ly/eXpandPodcastSpotify • Google Podcasts: https://bit.ly/eXpandPodcastGoogle

#theexpandpodcast #copd #healthcanada

Dans l'épisode de cette semaine du podcast eXpand, nous allons explorer comment la réadaptation pulmonaire, la technologie et le diagnostic précoce transforment le paysage du traitement de la MPOC.

Notre invité est le Dr François Maltais, directeur de la réadaptation pulmonaire et directeur de la recherche respiratoire à l'Institut de cardiologie et de pneumologie du Québec.

Aujourd'hui, vous apprendrez

• L'efficacité et l'accessibilité de la réadaptation pulmonaire

• Le rôle de la technologie dans la démocratisation de la réadaptation pulmonaire

• L'importance d'un diagnostic précoce de la MPOC

• Le rôle et les avantages des équipes multidisciplinaires dans les soins aux patients

• La nécessité d'un soutien du système de santé pour mettre en œuvre la réadaptation pulmonaire à plus grande échelle

Accédez à des ressources gratuites en rapport avec cet épisode : https://chroniclungdiseases.com/fr/nouvelles/vivre-plus-avec-la-mpoc

In today’s podcast episode we met with Dr. Mohit Bhutani from the University of Alberta to talk about the world of COPD treatment and how it is evolving to provide better outcomes for patients.

You’ll learn about:

• The severity of COPD as a leading cause of hospitalizations and its potential for treatment improvement.
• The significance of integrating both non-pharmacological and pharmacological treatments in managing COPD effectively.
• How standardized treatment protocols have the potential to reduce mortality rates and change the landscape of COPD care.

Access free resources related to this episode: https://chroniclungdiseases.com/en/news/copd-ignored-killer/

Watch more episodes related to COPD: https://www.youtube.com/playlist?list=PLKERLVA6ikI5K7cWnokHO9CFyvmTCDEp2

#copd #theexpandpodcast

In today's podcast episode, we met with Henry Roberts from COPD Canada to talk about COPD, how it affects people, and the work of COPD Canada to give patients a stronger voice.

You’ll learn:

- The impact of COVID-19 on COPD patients

- The role and objectives of COPD Canada

- The importance of spirometry testing in diagnosing COPD

- The potential future risks of COPD from new exposures like marijuana and e-cigarettes

Access free resources related to this episode: https://chroniclungdiseases.com/en/news/copd-ignored-epidemic/

Listen to more episodes related to COPD: https://www.youtube.com/playlist?list=PLKERLVA6ikI5K7cWnokHO9CFyvmTCDEp2

#copd #theexpandpodcast

Dans ce nouvel épisode, Maria Sedeno et le Dr Maxime Cormier discuteront des besoins potentiels en éducation pour la formation du doctorat en médecine et la formation spécialisée, ainsi que de ce qui est nécessaire au-delà du doctorat en médecine avec des programmes de formation continue afin de combler les lacunes actuelles.

Accédez au rapport et apprenez-en davantage sur l'Initiative canadienne contre la toux chronique : https://chroniclungdiseases.com/fr/nouvelles/linitiative-canadienne-sur-la-toux-chronique/?utm_source=youtube&utm_medium=socialmedia.

Dans cet épisode touchant et inspirant, nous donnons la parole à Nathalie Roussin, qui partage son vécu avec la MPOC et la déficience en alpha-1 antitrypsine. Elle raconte les débuts de sa maladie, les défis du diagnostic, et comment elle a appris à vivre pleinement avec une maladie chronique.Ce que vous apprendrez dans cet épisode :- Le rôle du diagnostic précoce dans la gestion de la MPOC- Les bénéfices concrets de la réhabilitation pulmonaire- L’importance du soutien émotionnel et social- Comment vivre activement malgré une maladie chronique- Les conseils de Nathalie pour mieux communiquer et s’engager dans sa santé👇 Pour en savoir plus et explorer d’autres ressources :🔹 Résumé de l’épisode et ressources : https://chroniclungdiseases.com/fr/nouvelles/mpoc-et-alpha-1/🔹 Module « Bien vivre avec la MPOC – DAAT » (gratuit) : https://chroniclungdiseases.com/fr/register-fr/🔹 Lignes directrices de la Société canadienne de thoracologie sur la DAAT : https://www.tandfonline.com/doi/full/10.1080/24745332.2024.2443178🔹 En savoir plus sur la saison 5 : https://chroniclungdiseases.com/fr/le-podcast-expand-saison-5-daat/🔹 Voir plus d’épisodes sur l’Alpha-1 : https://www.youtube.com/playlist?list=PLKERLVA6ikI5X8SabIgyphzutdp8RyKUBCe balado est produit par RESPIPLUS™, avec le soutien de Takeda Canada, pour sensibiliser à la déficience en alpha-1 antitrypsine et améliorer l’accès aux soins à travers le Canada.Les épisodes du balado The eXpand Podcast sont disponibles en anglais et en français, ou avec des sous-titres français dans la version anglaise.Abonnez-vous à The eXpand Podcast :• YouTube : https://bit.ly/eXpandPodcastYouTube• Apple Podcast : https://bit.ly/eXpandPodcastApple• Spotify : https://bit.ly/eXpandPodcastSpotify• Google Podcasts : https://bit.ly/eXpandPodcastGoogle#theexpandpodcast #alpha1 #aatdDéficit en alpha-1 antitrypsine, maladie pulmonaire, défense des patients, thérapie d’augmentation, accès aux soins, maladie pulmonaire obstructive chronique, maladie génétique, sensibilisation, diagnostic, traitement

Access the report and learn more about the Canadian Chronic Cough Initiative: https://chroniclungdiseases.com/en/news/canadian-chronic-cough-initiative/?utm_source=podcast&utm_medium=socialmedia

Join Dr. Cormier and Maria Sedeno to learn about the education that is needed in medical school programs and beyond regarding chronic cough.

Access the report and learn more about the Canadian Chronic Cough Initiative: https://chroniclungdiseases.com/en/news/canadian-chronic-cough-initiative/?utm_source=podcast&utm_medium=socialmedia

Join Dr. Alan Low and Sara McRae in our new episode to find out the role of a pharmacist in each patient's specific chronic cough journey.

Access the report and learn more about the Canadian Chronic Cough Initiative: https://chroniclungdiseases.com/en/news/canadian-chronic-cough-initiative/?utm_source=youtube&utm_medium=socialmedia

In our new episode, Dr Stephen Field, expert in the respiratory field, will discuss his unique experience and expertise with chronic cough clinics. Join him and Sara McRae to learn about the current status of chronic cough clinics in Canada and the challenges to set up one.

#respiplus #lunghealth #chroniccough

In this new episode, Maria Sedeno and Dr. Louis-Philippe Boulet will discuss the relationship between chronic cough and other respiratory conditions, such as upper and lower airways diseases. They will explore some of these relationships, their various presentations and mechanisms.

Access the report and learn more about the Canadian Chronic Cough Initiative: https://chroniclungdiseases.com/en/news/canadian-chronic-cough-initiative/?utm_source=podcast&utm_medium=socialmedia

#respiplus #lunghealth #chroniccough

Dans ce nouvel épisode, Maria Sedeno et le Dr Louis-Philippe Boulet aborderont la relation entre la toux chronique et d'autres affections respiratoires, telles que les maladies des voies respiratoires supérieures et inférieures. Ils exploreront certaines de ces relations, leurs différentes présentations et leurs mécanismes.

Accédez au rapport et apprenez-en davantage sur l'Initiative canadienne contre la toux chronique : https://chroniclungdiseases.com/fr/nouvelles/linitiative-canadienne-sur-la-toux-chronique/?utm_source=youtube&utm_medium=socialmedia

#respiplus #santépulmonaire

In this new episode, Sara McRae and Dr. Imran Satia will debunk some of the most common myths regarding chronic cough and go through what is specifically needed in Canada to help those with this disease.

Access the report and learn more about the Canadian Chronic Cough Initiative: https://chroniclungdiseases.com/en/news/canadian-chronic-cough-initiative/?utm_source=youtube&utm_medium=socialmedia

This podcast will bring you closer to experts in the respiratory field who will be discussing the best practices with a focus of improving the lives of people living with a chronic lung condition.

It is part of a series that explores the journey of people suffering with chronic cough and their healthcare team.

In today's episode, we'll be introducing Sara's story. Her story is particularly interesting, as she herself, is a respiratory therapist and was working in the asthma environment for a few years while suffering from undiagnosed chronic cough.

This in itself is a testimony to the lack of awareness around this condition.  We'll be joined by Dr. Alan Kaplan, who will comment on Sara's case. At the end of this episode, you'll have a better understanding of what it's like to live with chronic cough.

In this episode, Dr Simon Bacon provides specific strategies on how to engage your patients hesitancy for COVID vaccination. He talks about the key elements in motivational communication and disseminates the process for you to learn how to be as helpful with your patients as possible.

Dr Bacon is professor of Behavioural Medicine at Concordia University.

Watch our Free Webinar for Health Care Professionals: Helping You Address Patient Hesitancy for COVID-19 Vaccination

In today's episode, Dr Kim Lavoie talks about how to address vaccine hesitancy among your patients. She explains how to use evidence based communication strategies (ie. motivational communication) to understand your patients' thought process and increase their willingness to adopt healthy behaviours.

Watch our Free Webinar for Health Care Professionals: Helping You Address Patient Hesitancy for COVID-19 Vaccination

In this episode, Dr. Alan Kaplan discusses the significance of COVID-19 variants and deals briefly who may not be a suitable candidate for a COVID-19 vaccine.

Genetic variation might lower the vaccine's effectiveness against some of the new variants. However, there is still a degree of reduction of severe disease.

Watch our Free Webinar for Health Care Professionals: Helping You Address Patient Hesitancy for COVID-19 Vaccination

This episode of COVID Quotes was brought to you by Respiplus, creators of the Living Well With COPD program.

In Episode 2 of The Expand Podcast, Lee Andrew shares his journey living with Alpha-1 Antitrypsin Deficiency and emphysema. From early symptoms and delayed diagnosis to discovering treatment and embracing lifestyle changes, Lee’s story is one of resilience and empowerment.

Hosted by Dr. Jean Bourbeau, this conversation highlights the importance of early detection, access to care, and self-advocacy for patients with rare diseases like AATD.

This series is made possible thanks to support from Takeda Canada.

👉 Explore more: https://chroniclungdiseases.com/en/news/navigating-alpha-1-patient-journey/

#alpha-1 #aatd #respiplus

In today's episode, Dr. Alan Kaplan looks into the safety of COVID-19 vaccines and their potential side effects.

Watch our Free Webinar for Health Care Professionals: Helping You Address Patient Hesitancy for COVID-19 Vaccination

Free Webinar for Health Care Professionals: Addressing Patient Hesitancy for COVID-19 Vaccination

Welcome to COVID Quotes: short, informative audio clips about the safety and efficacy of COVID-19 vaccines and how to deal with vaccine hesitancy.

In our first episode, Dr. Alan Kaplan discusses the track record of vaccines in general and provides some basic information on COVID-19 vaccines and their effectiveness in Canada so far.

In our Season 5 premiere, we dive into Alpha-1 Antitrypsin Deficiency (AATD) — a rare but serious genetic condition that affects both the lungs and liver. People with AATD have a deficiency in a protein (alpha-1 antitrypsin) that normally protects lung tissue from inflammation. Without enough of this protein, individuals are at higher risk of developing lung conditions such as COPD, often at a younger age and even without a history of smoking.

Despite being underdiagnosed and often misunderstood, AATD affects thousands of Canadians. Raising awareness, improving access to testing, and advocating for equitable treatment is critical — and that’s where this episode begins.

Our special guest:

We’re joined by Angela Diano, Executive Director of AlphaNet Canada, who brings both professional expertise and personal insight into what it means to live with a chronic condition. With decades of experience in patient advocacy, Angela has played a key role in expanding access to augmentation therapy, influencing national policy, and empowering patients to take an active role in their care.

Access free resources related to this episode: https://chroniclungdiseases.com/en/news/breaking-down-aatd

More about Season 5: https://chroniclungdiseases.com/en/the-expand-podcast-season-5-aatd/

This podcast series was developed with support from Takeda Canada. Together, we’re working to raise awareness and improve care for those living with Alpha-1 across the country.

#aatd #theexpandpodcast

Alpha-1 antitrypsin deficiency, lung disease, patient advocacy, augmentation therapy, healthcare access, chronic obstructive pulmonary disease, genetic conditions, awareness, diagnosis, treatment

Navigating Inhaler Choices for Patients and the Environment | The eXpand Podcast In this episode of the eXpand Podcast, we delve into the complex considerations of selecting the right inhalers for patients with respiratory conditions, balancing patient care and environmental impacts. Our distinguished panel includes: • Pauline Anderson, Expert COPD Patient • Dr. Erika Penz, Specialist Respirologist at the Candy Interactive Society and President-Elect of the Canadian Thoracic Society (CTS) • Dr. Alan Kaplan, Family Physician and Chair of the Family Physicians Airways Group of Canada (FPAGC) Today you’ll learn about: • The critical role of inhalers in managing chronic respiratory conditions like COPD and asthma. • Personal experiences and challenges faced by patients using inhalers. • Environmental impacts of different types of inhalers and exploring eco-friendly alternatives. • Insights from the Canadian Thoracic Society's position on climate change and inhaler selection. • Practical advice for healthcare professionals on balancing effective patient care with environmental sustainability. Access free resources related to this episode: https://chroniclungdiseases.com/en/news/inhaler-choices-for-patients-and-the-environment/ Watch more episodes related to respiratory health: https://www.youtube.com/playlist?list=PLKERLVA6ikI7Q-UToML5HBvDkq7UWOIBE The eXpand Podcast episodes are available in English and French or with French subtitles available in the English version. Subscribe to The eXpand Podcast: • YouTube: https://bit.ly/eXpandPodcastYouTube • Apple Podcast: https://bit.ly/eXpandPodcastApple • Spotify: https://bit.ly/eXpandPodcastSpotify • Google Podcasts: https://bit.ly/eXpandPodcastGoogle #theexpandpodcast #COPD #asthma #environmentalhealth #respiratorycare #healthcanada #climatechange #inhalers #CTS #FPAGC

Family physicians play a critical role in managing chronic diseases, including COVID-19 and Long COVID.

In this episode of the eXpand Podcast, we’ll discuss the role of family physicians in managing COVID-19 and its long-term effects, known as Long COVID.

Our guest is Dr. Peter Lin, a Primary Care physician.

Access free resources related to this episode: https://chroniclungdiseases.com/en/news/primary-care-covid-19

Watch more episodes related to COVID-19: https://www.youtube.com/playlist?list=PLKERLVA6ikI7Q-UToML5HBvDkq7UWOIBE

#covid19 #theexpandpodcast

In our latest episode of the eXpand Podcast, we focused on the link between chronic respiratory conditions and COVID-19, the importance of prevention, available treatments, and the impact of these conditions on patients' lives.

Our guest is Dr. Maeve Smith, Assistant Professor in the Pulmonary Division of the University of Alberta.

Access free resources related to this episode: https://chroniclungdiseases.com/en/news/covid-19-impact-on-our-lungs

Watch more episodes related to COVID-19: https://www.youtube.com/playlist?list=PLKERLVA6ikI7Q-UToML5HBvDkq7UWOIBE

#covid19 #theexpandpodcast

The immune system is our defense against infections, with varying degrees of effectiveness depending on an individual's health conditions and age.

Chronic diseases like heart disease, diabetes, obesity, and others can weaken the immune system, making individuals more susceptible to severe outcomes from infections like COVID-19.

In today’s episode of the eXpand podcast we will focus on the immune system and its connection with COVID-19, the importance of COVID-19 vaccines and potential long-term complications of COVID-19, also known as "long COVID".

Our guest is Dr. Anne Ellis, professor in the Department of Medicine at Queen's University in Kingston and president of the Canadian Society of Allergy and Clinical Immunology (CSACI).

Today you’ll learn about:

• The link between the immune system and COVID-19.
• Risks and complications associated with COVID-19 for individuals with compromised immune systems.
• The importance of COVID-19 vaccines.
• The potential long-term effects of the virus.

Access free resources related to this episode: https://chroniclungdiseases.com/en/covid-19-and-immune-system

This episode was made in collaboration with the Canadian Society of Allergy and Clinical Immunology (CSACI).

Watch more episodes related to COVID-19: https://www.youtube.com/playlist?list=PLKERLVA6ikI7Q-UToML5HBvDkq7UWOIBE

#covid19 #theexpandpodcast

Endocrine diseases like diabetes and obesity can weaken the body's immunity and its ability to heal, potentially exacerbating the effects of COVID-19.

In today’s episode of the eXpand Podcast, we will focus on the relationship between these and COVID-19.

The discussion covers how these conditions can affect the body's response to the virus, the potential for long-term complications, and the importance of preventive measures.

Access free resources related to this episode: https://chroniclungdiseases.com/en/covid-19-and-endoncrine-diseases

Watch more episodes related to COVID-19: https://www.youtube.com/playlist?list=PLKERLVA6ikI7Q-UToML5HBvDkq7UWOIBE

#covid19 #theexpandpodcast

Early testing and treatment can make a critical difference in respiratory infections. In this episode of the eXpand podcast series, pharmacists Mike Boivin and Amy Lamb discuss the importance of rapid access to antivirals and timely care pathways in Indigenous and remote communities.This episode examines how early diagnosis and rapid treatment can improve outcomes in respiratory infections such as COVID-19 and influenza.Mike Boivin and Amy Lamb discuss barriers to testing and treatment in remote settings, the importance of culturally responsive communication, and how community-led pathways can support earlier intervention. The episode introduces the “Life Pathway” model, a practical framework for improving access to care.Learn more about this episode: http://chroniclungdiseases.com/en/early-treatment-respiratory-infections-remote-communitiesThis podcast is produced by RESPIPLUS™ with support from Pfizer to raise awareness about COVID-19 and improve access to care across Canada.This podcast series was developed with the valuable collaboration of organizations committed to improving patient care:- Indigenous Pharmacy Professionals of Canada: https://indigenouspharmacy.ca/- Lung Saskatchewan: https://www.lungsask.ca/The eXpand Podcast episodes are available in english and french or with french subtitles available in the english version.Subscribe to The eXpand Podcast: • YouTube: https://bit.ly/eXpandPodcastYouTube• Apple Podcast: https://bit.ly/eXpandPodcastApple• Spotify: https://bit.ly/eXpandPodcastSpotify• Google Podcasts: https://bit.ly/eXpandPodcastGoogle#theexpandpodcast #covid19

Vaccination remains one of the most important tools for preventing severe respiratory infections. In this episode of the eXpand Podcast, pharmacists Mike Boivin and Amy Lamb explore vaccination strategies in Indigenous communities and the importance of culturally safe healthcare approaches.This episode focuses on vaccines as a key strategy to reduce the burden of respiratory infections such as COVID-19, influenza, RSV, and pneumococcal disease.Mike Boivin and Amy Lamb discuss the realities of vaccine delivery in remote communities, including logistical challenges and the importance of culturally respectful engagement. The conversation highlights how trust, partnership, and community leadership are essential for effective vaccination initiatives.Learn more about this episode: http://chroniclungdiseases.com/en/respiratory-infection-risks-indigenous-communitiesThis podcast is produced by RESPIPLUS™ with support from Pfizer to raise awareness about COVID-19 and improve access to care across Canada.This podcast series was developed with the valuable collaboration of organizations committed to improving patient care:- Indigenous Pharmacy Professionals of Canada: https://indigenouspharmacy.ca/- Lung Saskatchewan: https://www.lungsask.ca/The eXpand Podcast episodes are available in english and french or with french subtitles available in the english version.Subscribe to The eXpand Podcast: • YouTube: https://bit.ly/eXpandPodcastYouTube• Apple Podcast: https://bit.ly/eXpandPodcastApple• Spotify: https://bit.ly/eXpandPodcastSpotify• Google Podcasts: https://bit.ly/eXpandPodcastGoogle#theexpandpodcast #covid19

Respiratory infections such as COVID-19, influenza, and RSV do not occur in isolation. In this episode of the RESPIPLUS podcast series, pharmacists Mike Boivin and Amy Lamb explore how chronic conditions, social determinants of health, and healthcare access barriers shape respiratory illness outcomes in Indigenous communities across Canada.This episode takes a deeper look at why respiratory infections can have different impacts across populations. The discussion focuses on the intersection of chronic disease, social determinants of health, and healthcare access.Mike Boivin and Amy Lamb highlight how conditions such as diabetes, COPD, and cardiovascular disease can increase vulnerability to respiratory infections. They also explore how trust, relationship-building, and community leadership play a critical role in improving health outcomes.Learn more about this episode: http://chroniclungdiseases.com/en/respiratory-infection-risks-indigenous-communitiesThis podcast is produced by RESPIPLUS™ with support from Pfizer to raise awareness about COVID-19 and improve access to care across Canada.This podcast series was developed with the valuable collaboration of organizations committed to improving patient care:- Indigenous Pharmacy Professionals of Canada: https://indigenouspharmacy.ca/- Lung Saskatchewan: https://www.lungsask.ca/The eXpand Podcast episodes are available in english and french or with french subtitles available in the english version.Subscribe to The eXpand Podcast: • YouTube: https://bit.ly/eXpandPodcastYouTube• Apple Podcast: https://bit.ly/eXpandPodcastApple• Spotify: https://bit.ly/eXpandPodcastSpotify• Google Podcasts: https://bit.ly/eXpandPodcastGoogle#theexpandpodcast #covid19

This opening episode introduces a series focused on respiratory infectious diseases and their impact in Indigenous communities across Canada. Pharmacists Mike Boivin and Amy Lamb explore how systemic barriers, healthcare access challenges, and social determinants of health influence outcomes during respiratory illness seasons.The discussion highlights both the structural issues affecting healthcare delivery and the resilience of Indigenous communities. The episode also sets the stage for future conversations about comorbidities, vaccination strategies, and practical prevention approaches.Learn more about this episode: http://chroniclungdiseases.com/en/respiratory-infections-indigenous-communitiesThis podcast is produced by RESPIPLUS™ with support from Pfizer to raise awareness about COVID-19 and improve access to care across Canada.This podcast series was developed with the valuable collaboration of organizations committed to improving patient care:- Indigenous Pharmacy Professionals of Canada: https://indigenouspharmacy.ca/- Lung Saskatchewan: https://www.lungsask.ca/The eXpand Podcast episodes are available in english and french or with french subtitles available in the english version.Subscribe to The eXpand Podcast: • YouTube: https://bit.ly/eXpandPodcastYouTube• Apple Podcast: https://bit.ly/eXpandPodcastApple• Spotify: https://bit.ly/eXpandPodcastSpotify• Google Podcasts: https://bit.ly/eXpandPodcastGoogle#theexpandpodcast #covid19

Pulmonary Arterial Hypertension: Early Diagnosis and Hope for PatientsPulmonary arterial hypertension is rare, serious, and often missed. Yet with early diagnosis and coordinated care, many patients can live well for years.In Episode 3 of the RESPIPLUS podcast series, Dr. Jean Bourbeau is joined by cardiologist Dr. Nathan Brunner to discuss pulmonary arterial hypertension through a cardiology lens. The episode focuses on why early detection matters, how multidisciplinary teams improve care, and what happens when diagnosis is delayed.Dr. Brunner also shares insights from his research on healthcare access, including rural and Indigenous populations, and outlines emerging opportunities in diagnostics and therapy that may shape the future of pulmonary hypertension care in Canada.This podcast is produced by RESPIPLUS™ with support from Merck to raise awareness about Alpha-1 and improve access to care across Canada.The eXpand Podcast episodes are available in english and french or with french subtitles available in the english version.Subscribe to The eXpand Podcast: • YouTube: https://bit.ly/eXpandPodcastYouTube• Apple Podcast: https://bit.ly/eXpandPodcastApple• Spotify: https://bit.ly/eXpandPodcastSpotify• Google Podcasts: https://bit.ly/eXpandPodcastGoogle#theexpandpodcast #pulmonaryarterialhypertension #pulmonaryhypertension

Pulmonary Hypertension in Canada: Awareness, Diagnosis, and ProgressPulmonary hypertension remains widely misunderstood, yet early recognition can profoundly change patient outcomes. In this episode, we explore how awareness, guidelines, and multidisciplinary care are reshaping pulmonary hypertension care in Canada.About this episodeIn Episode 2 of the RESPIPLUS podcast series, Dr. Jean Bourbeau speaks with Dr. Sanjay Mehta about the realities of pulmonary hypertension and pulmonary arterial hypertension in clinical practice. The conversation unpacks why diagnosis is often delayed, how classification informs care, and why multidisciplinary expertise is essential for optimal management.Dr. Mehta also reflects on how advances in treatment have transformed survival and quality of life for many patients, while highlighting ongoing gaps in access to care, particularly for people living outside major urban centres. The episode emphasizes the role of research, guidelines, and patient advocacy in improving outcomes across Canada.This podcast is produced by RESPIPLUS™ with support from Merck to raise awareness about Alpha-1 and improve access to care across Canada.The eXpand Podcast episodes are available in english and french or with french subtitles available in the english version.Subscribe to The eXpand Podcast: • YouTube: https://bit.ly/eXpandPodcastYouTube• Apple Podcast: https://bit.ly/eXpandPodcastApple• Spotify: https://bit.ly/eXpandPodcastSpotify• Google Podcasts: https://bit.ly/eXpandPodcastGoogle#theexpandpodcast #pulmonaryarterialhypertension #pulmonaryhypertension

In this Season 6 episode, we sit down with Jamie Myrah, Executive Director of the Pulmonary Hypertension Association of Canada. Interviewed by Dr. Jean Bourbeau, Jamie explores the complexity of pulmonary hypertension with a focus on pulmonary arterial hypertension. She explains what PAH is, why it is often difficult to diagnose, and how delays affect patients emotionally and socially.From her front-line perspective, Jamie highlights gaps in the healthcare system, the impact of specialized clinics, and how patient stories fuel advocacy, research, and access to treatments. The conversation underscores the urgent need for better diagnostic tools and the power of community support for people living with this rare disease.This podcast is produced by RESPIPLUS™ with support from Merck to raise awareness about Alpha-1 and improve access to care across Canada.The eXpand Podcast episodes are available in english and french or with french subtitles available in the english version.Subscribe to The eXpand Podcast: • YouTube: https://bit.ly/eXpandPodcastYouTube• Apple Podcast: https://bit.ly/eXpandPodcastApple• Spotify: https://bit.ly/eXpandPodcastSpotify• Google Podcasts: https://bit.ly/eXpandPodcastGoogle#theexpandpodcast #pulmonaryarterialhypertension #pulmonaryhypertension

Preventing respiratory infections requires preparation, collaboration, and community engagement. In this final episode of Season 7 of the eXpand podcast series, pharmacists Mike Boivin and Amy Lamb bring together key insights from the series to highlight practical strategies for prevention and community-centred care.In the concluding episode of the series, Mike Boivin and Amy Lamb focus on actionable strategies to reduce respiratory infection risks in Indigenous and remote communities.The discussion explores proactive planning for respiratory illness seasons, improving testing and treatment pathways, and strengthening partnerships between healthcare providers and communities. The episode emphasizes the importance of trust, cultural safety, and collaborative health leadership.Learn more about this episode: http://chroniclungdiseases.com/en/preventing-respiratory-infections-indigenous-communitiesThis podcast is produced by RESPIPLUS™ with support from Pfizer to raise awareness about COVID-19 and improve access to care across Canada.This podcast series was developed with the valuable collaboration of organizations committed to improving patient care:- Indigenous Pharmacy Professionals of Canada: https://indigenouspharmacy.ca/- Lung Saskatchewan: https://www.lungsask.ca/The eXpand Podcast episodes are available in english and french or with french subtitles available in the english version.Subscribe to The eXpand Podcast: • YouTube: https://bit.ly/eXpandPodcastYouTube• Apple Podcast: https://bit.ly/eXpandPodcastApple• Spotify: https://bit.ly/eXpandPodcastSpotify• Google Podcasts: https://bit.ly/eXpandPodcastGoogle#theexpandpodcast #covid19respiratory infections Indigenous communities,COVID-19 Indigenous health Canada,COPD Indigenous populations,antiviral access remote communities,vaccination Indigenous communities,RSV First Nations,respiratory health Métis Inuit,pharmacist Indigenous care,culturally safe healthcare,COPD comorbidities,influenza prevention remote Canada,Expand Podcast Respiplus,respiratory podcast healthcare professionals,COVID-19 antiviral treatment,Indigenous health equity

COPD has long been managed as a condition to be controlled rather than meaningfully altered. That view is shifting. As research into airway biology has advanced, it has become clear that COPD is a heterogeneous disease, and that targeting the right inflammatory pathway in the right patient can produce outcomes that were not previously possible.Learn more about this episode: http://chroniclungdiseases.com/en/copd-biologic-therapy-practical-guideRESPIPLUS™ received support from Sanofi to develop an informative podcast series specifically tailored to COPD Biologics.Subscribe to The eXpand Podcast: • YouTube: https://bit.ly/eXpandPodcastYouTube• Apple Podcast: https://bit.ly/eXpandPodcastApple• Spotify: https://bit.ly/eXpandPodcastSpotify• Google Podcasts: https://bit.ly/eXpandPodcastGoogle#theexpandpodcast #copdbiologicsCOPD biologics, biologic therapy COPD, dupilumab COPD, COPD treatment, eosinophils COPD, COPD exacerbations, precision medicine COPD, targeted COPD therapy, COPD clinical practice, COPD biomarkers, COPD management, respiratory health, chronic lung disease, COPD physician guide, pulmonary medicine, MPOC biologiques, traitement MPOC, médecine de précision

For decades, COPD was treated as a single, uniform disease. That's changing. A new generation of targeted therapies is making it possible to match treatment to patient biology, and the results from recent clinical trials are giving clinicians reason for optimism.In this episode, Dr. MeiLan Han explores what biologics actually do in the context of COPD, how blood eosinophil levels guide patient selection, and what the BOREAS and NOTUS trials tell us about real-world outcomes. She also addresses the practical challenges of integrating biologics into clinical practice, from interpreting biomarker variability to setting honest expectations with patients.Learn more about this episode: http://chroniclungdiseases.com/en/copd-biologics-era-precision-medicineRESPIPLUS™ received support from Sanofi to develop an informative podcast series specifically tailored to COPD Biologics.Subscribe to The eXpand Podcast: • YouTube: https://bit.ly/eXpandPodcastYouTube• Apple Podcast: https://bit.ly/eXpandPodcastApple• Spotify: https://bit.ly/eXpandPodcastSpotify• Google Podcasts: https://bit.ly/eXpandPodcastGoogle#theexpandpodcast #copdbiologicsCOPD biologics, biologic therapy COPD, dupilumab COPD, COPD treatment, eosinophils COPD, COPD exacerbations, precision medicine COPD, targeted COPD therapy, COPD clinical practice, COPD biomarkers, COPD management, respiratory health, chronic lung disease, COPD physician guide, pulmonary medicine, MPOC biologiques, traitement MPOC, médecine de précision